Inactive Instrument

Citicode Ltd. Stock Singapore S.E.

5FH

SG1Q38922098

Healthcare Facilities & Services

Livingstone Health Holdings Limited is a Singapore-based investment holding company. The Company is engaged in the provision of medical treatment and consultancy services. The Company operates through three segments: Specialist Healthcare, Primary Healthcare, and Others. Its Specialist Healthcare segment comprises anesthesiology and pain management; orthopedic surgery; dermatology; and internal medicine fields. Its Primary Healthcare segment includes services provided by general practitioners or family physicians, such as vaccination, musculoskeletal complaints, headaches, as well as diabetes, hypertension, dyslipidemia and asthma. The Others segment is in the business of aesthetic and wellness, allied health, managing healthcare solutions, consultancy functions, and provision of management services. Its brands include Livingstone Dermatology, Cove Aesthetic Clinic, Health Ardennes, Cove Orthopedic Clinic, and Atlas Podiatry.

Employees

Sector

Healthcare Facilities & Services

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	16.64M 13.03M 11.48M 10.87M 9.82M 18.5M 1.25B 18.74M 130M 50.07M 639M 48.94M 47.87M 2.05B	P/E 2025	28.8x	P/E 2026	83.6x
Enterprise Value	18.51M 14.5M 12.77M 12.09M 10.92M 20.58M 1.39B 20.85M 145M 55.69M 711M 54.43M 53.24M 2.28B	EV / Sales 2025	0.58x	EV / Sales 2026	0.6x
Free-Float	25.63%	Yield 2025 *	-	Yield 2026	-

05-26	Livingstone Health Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
04-27	Livingstone Health Allots and Issues Over 1.1 Million Shares	MT
03-04	Livingstone Health Unit Completes Acquisition of Wellington	MT
02-19	Livingstone Health announces proposed acquisition of Wellington Pte	RE
11-21	Livingstone Health Unit to Acquire Affinity Surgery Centre; Shares Down 3%	MT
11-13	Livingstone Health Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
11-13	Livingstone Health's Attributable Profit Jumps 78% in Fiscal H1	MT
30/09/25	Livingstone Health Holdings Limited Announces Change in Composition of the Board	CI
08/08/25	Livingstone Health Holdings Limited Re-Appoints Forvis Mazars LLP as Auditors	CI
30/05/25	Livingstone Health Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
26/05/25	Singapore Shares Slip as Trump Threatens EU With Huge Tariffs Before Extending Deadline	MT
26/05/25	Livingstone Health Expects Turnaround to Profit in Fiscal 2025; Shares Surge 15%	MT
23/05/25	Livingstone Health Holdings Limited Provides Earnings Guidance for the Six Months Interim Financial Period Ended 30 September 2024	CI

15/12/21	Livingstone Health : More Than 7,000 Registrations For Sinovac Coronavac® Inactivated Covid-19 Vaccines At Phoenix Medical Group Clinics	PU
02/11/21	General Announcement::PRESS RELEASE	PU
15/09/21	General Announcement::COMPLETION OF THE PROPOSED CAPITAL REDUCTION	PU
29/07/21	General Announcement::RESPONSE TO QUESTIONS FROM SIAS ON ANNUAL REPORT 2021	PU

Manager	Title	Age	Since
Ching Yit Tay CEO	Chief Executive Officer	47	04/02/2021
Qing Yuan Wong DFI	Director of Finance/CFO	45	08/07/2024
Yung Chuan Ng CTO	Chief Tech/Sci/R&D Officer	49	-

Director	Title	Age	Since
Wing Kwan Teh CHM	Chairman	54	27/06/2018
Heng Boo Fong BRD	Director/Board Member	76	20/07/2018
Yu Meng Chan BRD	Director/Board Member	55	20/07/2018

Citicode Ltd. Stock Singapore S.E.

Stocks

5FH

SG1Q38922098

Healthcare Facilities & Services

Valuation: Citicode Ltd.

Latest news: Citicode Ltd.

Press Releases: Citicode Ltd.

Managers and Directors: Citicode Ltd.

Hospitals, Clinics & Primary Care Services

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CITICODE LTD.	-.--%	-.--%	-	-	12.51M
CVS HEALTH CORPORATION	-1.62%	-0.20%	+13.66%	+22.73%	111B
HCA HEALTHCARE, INC.	-1.13%	-2.23%	+0.13%	+73.49%	93.45B
NATERA, INC.	-0.29%	+5.76%	+156.76%	+834.03%	59.75B
FRESENIUS SE & CO. KGAA	-4.87%	-4.41%	-6.75%	+50.03%	28.21B
QUEST DIAGNOSTICS INCORPORATED	+0.47%	+0.03%	+22.30%	+91.26%	25.6B
LABCORP HOLDINGS INC.	-0.23%	+1.36%	+7.33%	+53.25%	25.04B
TENET HEALTHCARE CORPORATION	-0.79%	-0.34%	+25.87%	+287.86%	20.74B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+3.24%	-0.44%	-16.11%	-3.86%	20.45B
IHH HEALTHCARE	-1.92%	-4.47%	-3.02%	+33.22%	17.03B
Average	-0.69%	-0.58%	+22.24%	+160.22%	44.63B
Weighted average by Cap.	-1.03%	-0.21%	+28.93%	+176.19%

	2025	2026
Net sales	27.66M 21.66M 19.07M 18.07M 16.31M 30.75M 2.08B 31.14M 216M 83.2M 1.06B 81.32M 79.55M 3.4B	29.32M 22.96M 20.22M 19.16M 17.29M 32.6M 2.2B 33.02M 229M 88.21M 1.13B 86.22M 84.34M 3.61B
Net income	557K 436K 384K 364K 328K 619K 41.78M 627K 4.35M 1.67M 21.36M 1.64M 1.6M 68.49M	223K 175K 154K 146K 132K 248K 16.74M 251K 1.74M 671K 8.56M 656K 641K 27.44M
Net Debt	1.91M 1.49M 1.32M 1.25M 1.13M 2.12M 143M 2.15M 14.92M 5.74M 73.25M 5.61M 5.49M 235M	1.87M 1.46M 1.29M 1.22M 1.1M 2.08M 140M 2.1M 14.6M 5.62M 71.71M 5.49M 5.37M 230M